Literature DB >> 15077109

The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development.

Heather J Hinton1, Dario R Alessi, Doreen A Cantrell.   

Abstract

T lymphocyte activation is associated with activation of diverse AGC serine kinases (named after family members protein kinase A, protein kinase G and protein kinase C). It has been difficult to assess the function of these molecules in T cell development with simple gene-deletion strategies because different isoforms of AGC kinases are coexpressed in the thymus and have overlapping, redundant functions. To circumvent these problems, we explored the consequences of genetic manipulation of phosphoinositide-dependent kinase 1 (PDK1), a rate-limiting 'upstream' activator of AGC kinases. Here we analyzed the effect of PDK1 deletion on T lineage development. We also assessed the consequences of reducing PDK1 levels to 10% of normal. Complete PDK1 loss blocked T cell differentiation in the thymus, whereas reduced PDK1 expression allowed T cell differentiation but blocked proliferative expansion. These studies show that AGC family kinases are essential for T cell development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077109     DOI: 10.1038/ni1062

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  60 in total

1.  HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes.

Authors:  Gladys W Wong; Gisele C Knowles; Tak W Mak; Adolfo A Ferrando; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

2.  Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP.

Authors:  Michelle M Collazo; Kim H T Paraiso; Mi-Young Park; Amy L Hazen; William G Kerr
Journal:  Eur J Immunol       Date:  2012-07       Impact factor: 5.532

3.  Stage-specific requirement of kinase PDK1 for NK cells development and activation.

Authors:  Junming He; Yuande Wang; Tian Liu; Guangao Liu; Shasha Chen; Qiaozhen Li; Yuhe Quan; Haoyan Yang; Jin Feng; Song Wang; Meixiang Yang; Zhongjun Dong
Journal:  Cell Death Differ       Date:  2019-01-08       Impact factor: 15.828

4.  Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells.

Authors:  Joby J Westmoreland; Qian Wang; Mohamed Bouzaffour; Suzanne J Baker; Beatriz Sosa-Pineda
Journal:  Dev Biol       Date:  2009-07-25       Impact factor: 3.582

5.  Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells.

Authors:  Caroline E von Allmen; Nicole Schmitz; Monika Bauer; Heather J Hinton; Michael O Kurrer; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Tim Sparwasser; Roger R Beerli; Martin F Bachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

6.  Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.

Authors:  Po-Chien Chou; Won Jun Oh; Chang-Chih Wu; Joseph Moloughney; Markus A Rüegg; Michael N Hall; Estela Jacinto; Guy Werlen
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 7.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint.

Authors:  Ling Xue; Leslie Chiang; Chulho Kang; Astar Winoto
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

9.  Transition from heterotypic to homotypic PDK1 homodimerization is essential for TCR-mediated NF-κB activation.

Authors:  Jung-Ah Kang; Sang Phil Jeong; Daeho Park; Matthew S Hayden; Sankar Ghosh; Sung-Gyoo Park
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

10.  Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance.

Authors:  Jose R Bayascas; Stephan Wullschleger; Kei Sakamoto; Juan M García-Martínez; Carol Clacher; David Komander; Daan M F van Aalten; Krishna M Boini; Florian Lang; Christopher Lipina; Lisa Logie; Calum Sutherland; John A Chudek; Janna A van Diepen; Peter J Voshol; John M Lucocq; Dario R Alessi
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.